The consensus analyst price target for Novavax stock has edged up from $12.50 to $13.21, reflecting an evolving outlook as the company navigates a transition in its business strategy. This shift ...

FHFA Director Bill Pulte announces a review of loan-level price adjustments led by Barry Habib, potentially impacting ...

Novavax, Inc. (NASDAQ:NVAX) is one of the top long-term biotechnology stocks to buy. On October 24, Cantor Fitzgerald ...

Built upon these three commitments, ExmBit offers a distinctive trading ecosystem: ...

Compared to last year, Netflix's ad revenue this year is all set to double. The revenue last quarter was $11.5 billion -- 17% ...

US sanctions waiver on Chabahar port project reinstated for 6 months. India assesses the impact on trade, energy security and ...

Bending Spoon's four cofounders have become billionaires after a takeover of AOL and other deals landed the Milan startup ...

Petrol marketers have warned Nigerians that the new 15% import tariff approved by President Tinubu could push fuel prices ...

These three companies are all delivering rack-scale infrastructure to compete with Nvidia's NVL72 class system for inference.

The latest update is out from Matrix Holdings Limited ( (HK:1005) ).

Research from the Brookings Institution notes that, despite broader geographic diversification, the Bay Area continues to ...

After hustling for decades to get to the big stage, Zaslav is eager to prove critics wrong and complete a turnaround after ...